Новости
|
Журнал включен в систему цитирования Scopus |
---|
2022 г. №5 Том 30
ОБЗОРЫ
С.В. ЯКУБОВСКИЙ 1, Г.Г. КОHДРАТЕHКО 1, В.А. ЛЕМЕШ 2, В.Н. КИПЕHЬ 2
НОВООБРАЗОВАHИЯ ЩИТОВИДHОЙ ЖЕЛЕЗЫ: РОЛЬ МОЛЕКУЛЯРHЫХ МАРКЕРОВ В ДИФФЕРЕHЦИАЛЬHОЙ ДИАГHОСТИКЕ И ВЫБОРЕ ЛЕЧЕБHОЙ ТАКТИКИ
УО «Белорусский государственный медицинский университет» 1,
ГНУ «Институт генетики и цитологии Национальной академии наук Беларуси» 2, г. Минск,
Республика Беларусь
Узловой зоб является широко распространенной патологией щитовидной железы. Установление морфологической природы этих узловых образований основывается на комплексном обследовании, включающем тонкоигольную аспирационную биопсию, являющуюся окончательным методом верификации диагноза на дооперационном этапе. Однако до 20-30% заключений тонкоигольной аспирационной биопсии может носить неопределенный характер, что затрудняет выбор адекватной лечебной тактики. Исследования, проведенные в последние десятилетия, позволили приблизиться к пониманию генетических механизмов возникновения и развития рака щитовидной железы. Эти данные обусловили попытки использовать молекулярно-генетическое тестирование для дифференциальной диагностики узловых образований щитовидной железы.
В статье представлен обзор наиболее распространенных молекулярно-генетических панелей, описаны факторы, влияющие на их диагностическую эффективность, обсуждены показания и условия применения молекулярного тестирования в клинической практике.
- Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest. 2009 Aug;39(8):699-706. doi: 10.1111/j.1365-2362.2009.02162.x
- Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71. doi: 10.1056/NEJMcp031436
- Baloch ZW, LiVolsi VA. Current role and value of fine-needle aspiration in nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):531-44. doi: 10.1016/j.beem.2014.01.010
- Лущик МЛ, Валуевич ВВ, Григорович АС, Корытько СС, Караник ВС, Дрозд ВМ, Демидчик ЮЕ, Данилова ЛИ. Метод дифференциальной диагностики новообразований щитовидной железы: инструкция по применению. Минск, РБ; 2015. 15 с.
- Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-37 doi: 10.1002/dc.20830
- Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017 Nov;27(11):1341-46. doi: 10.1089/thy.2017.0500
- Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis. Acta Cytol. 2012;56(4):333-39. doi: 10.1159/000339959
- Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ 3rd, Ganly I, Hodak SP, Kebebew E, Patel KN, Shaha A, Steward DL, Tufano RP, Wiseman SM, Carty SE; American Thyroid Association Surgical Affairs Committee. American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid. 2015 Jul;25(7):760-68. doi: 10.1089/thy.2014.0502
- Jegerlehner S, Bulliard JL, Aujesky D, Rodondi N, Germann S, Konzelmann I, Chiolero A; NICER Working Group. Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. PLoS One. 2017 Jun 14;12(6):e0179387. doi: 10.1371/journal.pone.0179387. eCollection 2017.
- Miccoli P, Biricotti M, Matteucci V, Ambrosini CE, Wu J, Materazzi G. Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed. Surg Endosc. 2016 Jun;30(6):2489-95. doi: 10.1007/s00464-015-4503-4
- Ha SM, Sung JY, Baek JH, Na DG, Kim JH, Yoo H, Lee D, Whan Choi D. Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes. Int J Hyperthermia. 2017 Dec;33(8):931-37. doi: 10.1080/02656736.2017.1331268
- Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014 Oct 23;159(3):676-90. doi: 10.1016/j.cell.2014.09.050
- Ji JH, Oh YL, Hong M, Yun JW, Lee HW, Kim D, Ji Y, Kim DH, Park WY, Shin HT, Kim KM, Ahn MJ, Park K, Sun JM. Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet. 2015 Aug 21;11(8):e1005467. doi: 10.1371/journal.pgen.1005467. eCollection 2015 Aug.
- Kunstman JW, Juhlin CC, Goh G, Brown TC, Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams C, Mane S, Rimm DL, Prasad ML, Höög A, Zedenius J, Larsson C, Korah R, Lifton RP, Carling T. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet. 2015 Apr 15;24(8):2318-29. doi: 10.1093/hmg/ddu749
- Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271
- Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018 Mar 6;319(9):914-924. doi: 10.1001/jama.2018.0898
- Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab. 2011 Nov;96(11):3390-97. doi: 10.1210/jc.2011-1469
- Steward DL, Kloos RT. Clinical diagnostic gene expression thyroid testing. Otolaryngol Clin North Am. 2014 Aug;47(4):573-93. doi: 10.1016/j.otc.2014.04.009
- Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009 Jan;19(1):92-105. doi: 10.1101/gr.082701.108
- Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012 Mar;4(3):143-59. doi: 10.1002/emmm.201100209
- Boufraqech M, Klubo-Gwiezdzinska J, Kebebew E. MicroRNAs in the thyroid. Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):603-19. doi: 10.1016/j.beem.2016.10.001
- Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab. 2008 May;93(5):1600-8. doi: 10.1210/jc.2007-2696
- Mancikova V, Castelblanco E, Pineiro-Yanez E, Perales-Paton J, de Cubas AA, Inglada-Perez L, Matias-Guiu X, Capel I, Bella M, Lerma E, Riesco-Eizaguirre G, Santisteban P, Maravall F, Mauricio D, Al-Shahrour F, Robledo M. MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors. Mod Pathol. 2015 Jun;28(6):748-57. doi: 10.1038/modpathol.2015.44
- Chu YH, Lloyd RV. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression. Endocr Pathol. 2016 Dec;27(4):312-24. doi: 10.1007/s12022-016-9449-0
- Fuziwara CS, Kimura ET. MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology. Int J Endocrinol. 2014;2014:743450. doi: 10.1155/2014/743450
- Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M. MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Oncol. 2017 May;50(5):1767-77. doi: 10.3892/ijo.2017.3960
- Lara OD, Wang Y, Asare A, Xu T, Chiu HS, Liu Y, Hu W, Sumazin P, Uppal S, Zhang L, Rauh-Hain JA, Sood AK. Pan-cancer clinical and molecular analysis of racial disparities. Cancer. 2020 Feb 15;126(4):800-807. doi: 10.1002/cncr.32598
- Kim J, Park WJ, Jeong KJ, Kang SH, Kwon SY, Kim S, Park JW. Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.Int J Genomics. 2017;2017:5789769. doi: 10.1155/2017/5789769
- Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005 Jun;12(2):245-62. doi: 10.1677/erc.1.0978
- Nikiforov YE. Role of molecular markers in thyroid nodule management: then and now. Endocr Pract. 2017 Aug;23(8):979-88. doi: 10.4158/EP171805.RA
- Nishino M, Krane JF. Role of Ancillary Techniques in Thyroid Cytology Specimens. Acta Cytol. 2020;64(1-2):40-51. doi: 10.1159/000496502
- Labourier E, Shifrin A, Busseniers AE, Lupo MA, Manganelli ML, Andruss B, Wylie D, Beaudenon-Huibregtse S. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. J Clin Endocrinol Metab. 2015 Jul;100(7):2743-50. doi: 10.1210/jc.2015-1158
- Lupo MA, Walts AE, Sistrunk JW, Giordano TJ, Sadow PM, Massoll N, Campbell R, Jackson SA, Toney N, Narick CM, Kumar G, Mireskandari A, Finkelstein SD, Bose S. Multiplatform molecular test performance in indeterminate thyroid nodules. Diagn Cytopathol. 2020 Dec;48(12):1254-64. doi: 10.1002/dc.24564
- Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, Figge JJ, Mandel S, Haugen BR, Burman KD, Baloch ZW, Lloyd RV, Seethala RR, Gooding WE, Chiosea SI, Gomes-Lima C, Ferris RL, Folek JM, Khawaja RA, Kundra P, Loh KS, Marshall CB, Mayson S, McCoy KL, Nga ME, Ngiam KY, Nikiforova MN, Poehls JL, Ringel MD, Yang H, Yip L, Nikiforov YE. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019 Feb 1;5(2):204-212. doi: 10.1001/jamaoncol.2018.4616
- Marti JL, Avadhani V, Donatelli LA, Niyogi S, Wang B, Wong RJ, Shaha AR, Ghossein RA, Lin O, Morris LG, Ho AS. Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules. Ann Surg Oncol. 2015 Nov;22(12):3996-4001. doi: 10.1245/s10434-015-4486-3
- Patel KN, Angell TE, Babiarz J, Barth NM, Blevins T, Duh QY, Ghossein RA, Harrell RM, Huang J, Kennedy GC, Kim SY, Kloos RT, LiVolsi VA, Randolph GW, Sadow PM, Shanik MH, Sosa JA, Traweek ST, Walsh PS, Whitney D, Yeh MW, Ladenson PW. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules. JAMA Surg. 2018 Sep 1;153(9):817-824. doi: 10.1001/jamasurg.2018.1153
- Duh QY, Busaidy NL, Rahilly-Tierney C, Gharib H, Randolph G. A Systematic Review of the Methods of Diagnostic Accuracy Studies of the Afirma Gene Expression Classifier. Thyroid. 2017 Oct;27(10):1215-1222. doi: 10.1089/thy.2016.0656.
- Partyka KL, Randolph ML, Lawrence KA, Cramer H, Wu HH. Utilization of direct smears of thyroid fine-needle aspirates for ancillary molecular testing: A comparison of two proprietary testing platforms. Diagn Cytopathol. 2018 Apr;46(4):320-325. doi: 10.1002/dc.23902
- Livhits MJ, Kuo EJ, Leung AM, Rao J, Levin M, Douek ML, Beckett KR, Zanocco KA, Cheung DS, Gofnung YA, Smooke-Praw S, Yeh MW. Gene Expression Classifier vs Targeted Next-Generation Sequencing in the Management of Indeterminate Thyroid Nodules. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2261-68. doi: 10.1210/jc.2017-02754
- Al-Qurayshi Z, Deniwar A, Thethi T, Mallik T, Srivastav S, Murad F, Bhatia P, Moroz K, Sholl AB, Kandil E. Association of Malignancy Prevalence With Test Properties and Performance of the Gene Expression Classifier in Indeterminate Thyroid Nodules. JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):403-408. doi: 10.1001/jamaoto.2016.3526
- Valderrabano P, Hallanger-Johnson JE, Thapa R, Wang X, McIver B. Comparison of Postmarketing Findings vs the Initial Clinical Validation Findings of a Thyroid Nodule Gene Expression Classifier: A Systematic Review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2019 Sep 1;145(9):783-792. doi: 10.1001/jamaoto.2019.1449
- Marcadis AR, Valderrabano P, Ho AS, Tepe J, Swartzwelder CE, Byrd S, Sacks WL, Untch BR, Shaha AR, Xu B, Lin O, Ghossein RA, Wong RJ, Marti JL, Morris LGT. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules. Surgery. 2019 Jan;165(1):17-24. doi: 10.1016/j.surg.2018.04.062
- Jug R, Foo WC, Jones C, Ahmadi S, Jiang XS. High-risk and intermediate-high-risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution. Cancer Cytopathol. 2020 Aug;128(8):563-69. doi: 10.1002/cncy.22283
- San Martin VT, Lawrence L, Bena J, Madhun NZ, Berber E, Elsheikh TM, Nasr CE. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz099. doi: 10.1210/clinem/dgz099
- Корнеенков АА, Рязанцев СВ, Вяземская ЕЭ. Вычисление и интерпретация показателей информативности диагностических медицинских технологий. Mед Совет. 2019;(20):45-51. doi: 10.21518/2079-701X-2019-20-45-51
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020
- Paschke R, Cantara S, Crescenzi A, Jarzab B, Musholt TJ, Simoes MS. European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics. Eur Thyroid J. 2017 Jul;6(3):115-29. doi: 10.1159/000468519
- Ohori NP, Schoedel KE. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Acta Cytol. 2011;55(6):492-98. doi: 10.1159/000334218
- Cibas ES, Baloch ZW, Fellegara G, LiVolsi VA, Raab SS, Rosai J, Diggans J, Friedman L, Kennedy GC, Kloos RT, Lanman RB, Mandel SJ, Sindy N, Steward DL, Zeiger MA, Haugen BR, Alexander EK. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013 Sep 3;159(5):325-32. doi: 10.7326/0003-4819-159-5-201309030-00006
- Parajuli S, Jug R, Ahmadi S, Jiang XS. Hurthle cell predominance impacts results of Afirma gene expression classifier and ThyroSeq molecular panel performance in indeterminate thyroid nodules. Diagn Cytopathol. 2019 Nov;47(11):1177-83. doi: 10.1002/dc.24290
- Hernandez-Prera JC, Valderrabano P, Creed JH, de la Iglesia JV, Slebos RJC, Centeno BA, Tarasova V, Hallanger-Johnson J, Veloski C, Otto KJ, Wenig BM, Yoder SJ, Lam CA, Park DS, Anderson AR, Raghunand N, Berglund A, Caudell J, Gerke TA, Chung CH. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and RAS Mutations. Thyroid. 2021 Jan;31(1):36-49. doi: 10.1089/thy.2019.0650
- Najafian A, Noureldine S, Azar F, Atallah C, Trinh G, Schneider EB, Tufano RP, Zeiger MA. RAS Mutations, and RET/PTC and PAX8/PPAR-gamma Chromosomal Rearrangements Are Also Prevalent in Benign Thyroid Lesions: Implications Thereof and A Systematic Review. Thyroid. 2017 Jan;27(1):39-48. doi: 10.1089/thy.2016.0348
- Zanocco KA, Wang MM, Yeh MW, Livhits MJ. Selective use of Molecular Testing Based on Sonographic Features of Cytologically Indeterminate Thyroid Nodules: A Decision Analysis. World J Surg. 2020 Feb;44(2):393-401. doi: 10.1007/s00268-019-05177-7
- Najafzadeh M, Marra CA, Lynd LD, Wiseman SM. Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer. Value Health. 2012 Dec;15(8):1005-13. doi: 10.1016/j.jval.2012.06.017
220116, Республика Беларусь,
г. Минск, пр. Дзержинского, 83,
Белорусский государственный
медицинский университет,
кафедра хирургии и трансплантологии,
тел. офис: +375 017 3400252,
e-mail: yakub-2003@yandex.ru,
Якубовский Сергей Васильевич
Якубовский Сергей Владимирович, к.м.н., доцент 1-й кафедры хирургических болезней УО «Белорусский государственный медицинский университет», г. Минск, Республика Беларусь.
https://orcid.org/0000-0003-3759-7050
ККондратенко Геннадий Георгиевич, д.м.н., профессор, профессор кафедры хирургии и трансплантологии УО «Белорусский государственный медицинский университет», г. Минск, Республика Беларусь.
https://orcid.org/0000-0001-5295-1068
Лемеш Валентина Александровна к.б.н., доцент, руководитель лаборатории генетической и клеточной инженерии ГНУ «Институт генетики и цитологии Национальной академии наук Беларуси»г. Минск, Республика Беларусь.
https://orcid.org/0000-0003-1348-8642
Кипень Вячеслав Николаевич к.б.н., ведущий научный сотрудник лаборатории генетической и клеточной инженерии ГНУ «Институт генетики и цитологии Национальной академии наук Беларуси», г. Минск, Республика Беларусь.
https://orcid.org/000-0002-7822-0746